Medical devices, healthcare technology and the business of care
510(k) clearance · K260714

MammoScreen (5)

Therapixel · Decision date Jun 26, 2026

FDA DECISIONK260714

What did the FDA decide?

FDA records K260714 as a 510(k) premarket notification, with a decision dated Jun 26, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Radiology
Decision date
Jun 26, 2026

FDA source record

Regulatory record facts

Identifier
K260714
Regulatory pathway
510(k) premarket notification
Applicant
Therapixel
Product code
QDQ
Decision code
SESE
Decision date
Jun 26, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Radiological Computer Assisted Detection/Diagnosis Software For Lesions Suspicious For Cancer.

Applicant
Therapixel
Product code
QDQ
FDA device class
2

FDA decision timeline

  1. K260714 received

    Application receipt date recorded by FDA.

  2. K260714 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code QDQ

Product / regulatory recordCompanyPathwayDecision dateSource
CadAI-B DxK263749
BeamWorks, Inc.510(k) clearanceNov 6, 2026FDA
Qure.Ai Technologies Pvt. , Ltd.510(k) clearanceSep 14, 2026FDA
Screenpoint Medical B.V.510(k) clearanceAug 14, 2026FDA
CadAI-B DxK260086
BeamWorks, Inc.510(k) clearanceAug 12, 2026FDA
See-Mode Technologies Pty, Ltd.510(k) clearanceJul 28, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Therapixel

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Nice

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records